(Press-News.org) BIRMINGHAM, Ala. – In the summer of 2018, graduate student Hunter Dean from the Medical Scientist Training Program came to Yuhua Song, Ph.D., with a research idea. He wanted to pursue his doctoral research at the University of Alabama at Birmingham in Alzheimer’s disease — under the joint mentorship of Song, who had never worked in Alzheimer’s, and Erik Roberson, M.D., Ph.D., an Alzheimer’s expert in the UAB Department of Neurology and the Center for Neurodegeneration and Experimental Therapeutics, or CNET.
That collaboration brought Song, a professor in the UAB Department of Biomedical Engineering, into research on this leading cause of dementia worldwide. In addition, the collaboration has now garnered $5.68 million of grant support — proceeding from a $660,000 award from the Alzheimer’s Drug Discovery Foundation in 2019 with Roberson as principal investigator and Song as co-investigator to two awards with Song as PI and Roberson as co-investigator — a five-year $2.13 million National Institutes of Health R01 grant in 2021 and a five-year $2.89 million NIH R01 grant this summer.
The strength that Song brought into this unusual collaboration is computational biology — using supercomputers to model a key Alzheimer’s protein called TREM2 and its interactions with small chemical molecules. These molecules include both ligands produced in the body and existing drugs that are prescribed for other diseases but may also prove useful to treat Alzheimer’s. Integrated computational modeling on UAB’s Cheaha Supercomputer can identify drugs that should bind to TREM2 — first searching from a database of more than 80,000 human metabolites and then from a library of more than 6,000 drugs, including preclinical drugs, clinical trial drugs, and existing U.S. Food and Drug Administration-approved drugs. Hits identified by the unbiased virtual screening can then be validated with biophysical and biological experiments.
Why is TREM2 important? Genome-wide association studies have found that single amino acid variants in TREM2 are one of the strongest genetic risk factors for late-onset Alzheimer’s disease. This means TREM2 could hold a key to progress in finding a drug to treat the disease.
TREM2 is a transmembrane receptor protein found on microglial cells, the resident macrophages in the central nervous system. In these brain immune cells, TREM2 can act to stimulate phagocytosis by the microglia to remove damaged cells, or TREM2 can act to suppress inflammation.
“New knowledge gained from this study could have a major impact for Alzheimer’s disease research and treatment,” Song said. “By repositioning available drugs, we can search for new drug combinations to target TREM2 for Alzheimer’s disease treatment.”
In previous studies, Song’s team identified two ligand-binding sites in TREM2, including a basic site that contains most of the Alzheimer’s disease-associated residues on TREM2, and a hydrophobic site that resembles the complementarity-determining regions that give antibodies their specificity. The hypothesis in Song’s research is that available drugs, including FDA-approved drugs, could bind TREM2 at either its basic and/or hydrophobic binding sites.
Binding of a molecule to a protein can have an allosteric effect — a change in the protein’s conformation that can either boost or diminish its activity. This allosteric effect caused by drug(s) binding at either site could drive TREM2-mediated immune activities as a treatment for Alzheimer’s disease, even in the presence of TREM2 variants that are associated with increased risk of late-onset Alzheimer’s. These potential drugs will then be validated in macrophages and microglia, looking for the drugs that best activate phagocytosis and cytoprotection.
Dean, a student in UAB’s Medical Scientist Training Program and the instigator of Song and Roberson’s synergistic TREM2 research, is now known as Hunter Dean, Ph.D. He has moved on to finishing his M.D. studies after successfully defending his dissertation this summer. Song says both Dean and Ph.D. graduate student Rory Greer have been invaluable contributors in the TREM2 research.
Collaborating with Song and Roberson on her 2023 NIH R01 grant is Thomas Brett, Ph.D., Washington University, St. Louis, Missouri.
At UAB, Biomedical Engineering is a joint department in the Marnix E. Heersink School of Medicine and the School of Engineering, and Neurology is a department in the Heersink School of Medicine. Roberson holds the Rebecca Gale Endowed Professorship for Alzheimer’s Disease and is the director of CNET and the NIH-funded Alzheimer’s Disease Center at UAB.
END
Alzheimer’s: An M.D./Ph.D. graduate student’s request for Yuhua Song as mentor leads to two NIH R01 awards totaling $5 million
The M.D./Ph.D. student has since moved on to clinical studies, but the research into possible drugs to treat Alzheimer’s disease continues.
2023-09-12
ELSE PRESS RELEASES FROM THIS DATE:
Recommendations for addressing health-related social needs in cancer care introduced at NCCN Policy Summit
2023-09-12
Today, the National Comprehensive Cancer Network® (NCCN®)—an alliance of leading cancer centers—presented new recommendations for screening and addressing health-related social needs (HRSN) in people with cancer during a policy summit in Washington, D.C. The event included a keynote address from Ellen Lukens, Deputy Administrator and Director, The Center for Medicare and Medicaid Innovation (CMMI), and other speakers representing a diverse group of patient advocates, providers, and policymakers.
The new recommendations for measuring and addressing HRSNs were ...
West Health-Gallup Poll: 70% of Americans uncomfortable with prospect of being admitted to nursing home
2023-09-12
WASHINGTON, D.C. — September 12, 2023 — More than 40% of Americans say nursing homes are unsafe and 7 in 10 say they would be uncomfortable ever having to be admitted to one even if they needed such care, while more than six in 10 (61%) feel similarly anxious about the prospect of admitting family members, according to the latest survey from West Health and Gallup.
Safety was a particular area of perceived concern; 41% of respondents say nursing homes are not safe, 26% say they are, and about a third say they don’t know. Notably, the survey found that people over 35 were much ...
UTHealth Houston researcher to present abstract detailing new mouse model for brain arteriovenous malformations at NIH meeting
2023-09-12
An abstract unveiling a new mouse model for brain arteriovenous malformations (AVMs) developed by UTHealth Houston researchers has been selected for a poster presentation at the second annual National Institutes of Health (NIH) Investigator Meeting for Interoception Research in November.
Eunsu Park, PhD, assistant professor in the Vivian L. Smith Department of Neurosurgery with McGovern Medical School at UTHealth Houston, will present the abstract at the meeting, hosted by the National Center for Complementary and Integrative Health (NCCIH) at the NIH campus in Bethesda, Maryland, on Nov. ...
Combination of stressors key to testing perovskite solar cells
2023-09-12
Perovskite solar cells should be subjected to a combination of stress tests simultaneously to best predict how they will function outdoors, according to researchers at the U.S. Department of Energy’s National Renewable Energy Laboratory (NREL).
Solar cells must endure a set of harsh conditions—often with variable combinations of changing stress factors—to judge their stability, but most researchers conduct these tests indoors with a few fixed stressing conditions. While these tests provide some necessary insight, understanding which stressor applied during indoor tests provided predictive correlations ...
Communicating stability, strong connections to stakeholders versus shareholders are priorities in Chinese financial reporting, Rotman research finds
2023-09-12
September 12, 2023 Toronto - It’s commonly accepted that U.S. and Chinese companies treat financial reporting and disclosure differently.
New research not only confirms that but digs into the motivations behind the distinction, using surveys with more than 200 Chinese executives who hold reporting responsibility. An overriding interest in communicating long-term stability and inspiring confidence in the company’s prospects among a diverse range of stakeholders, and not primarily shareholders, as in the U.S., was a signature driver for the Chinese business leaders.
“Acknowledging differences in approaches and incentives ...
Morris Animal Foundation funds 6 new studies to advance canine cancer research
2023-09-12
DENVER/Sept. 12, 2023 – Recent findings from the Golden Retriever Lifetime Study confirm the enormous impact of hemangiosarcoma on golden retrievers. To address critical gaps in disease detection and treatment, Morris Animal Foundation announced it is funding six studies focused on this deadly form of canine cancer.
“We are committed to providing resources to the top research teams in the world that can advance our understanding of hemangiosarcoma," said Dr. Kathy Tietje, Chief Program Officer at Morris Animal Foundation. "These innovative research ...
ReMDO grants support commercialization of regenerative medicine therapies
2023-09-12
WINSTON-SALEM, NC, September 12, 2023 - When the RegenMed Development Organization (ReMDO) offered its grant opportunity related to regenerative medicine manufacturing and commercialization, the result exceeded expectations.
The Regenerative Medicine Manufacturing grant call encouraged small, medium, and large companies to submit letters of interest with an accompanying white paper that addressed a gap in technical capabilities for one or more of the following topic areas: Cell and Biomaterial Manufacturing, Standards and Quality Control, Additive Manufacturing and Artificial Intelligence (AI) and Automation.
The grant opportunity will ...
Breast cancer recurrence may be triggered by chemotherapy injury to non-cancer cells
2023-09-12
A standard chemotherapy drug injures surrounding non-cancer cells, which can then awakens dormant cancer cells and promotes cancer growth, according to a new study publishing September 12th in the open access journal PLOS Biology by Ramya Ganesan of Emory University, US, and colleagues. The finding is important for understanding cancer recurrence and may point to important new targets to prevent it.
Advances in cancer treatment, including chemotherapy, have dramatically reduced mortality for many types of cancer, including breast cancer. Nonetheless, up to 23% of breast cancer patients experience recurrence within the first five years. Treatment is meant to kill all cancer cells, ...
Disease-resistant rice and wheat plants may modulate disease susceptibility in their neighbors
2023-09-12
Growing several plant varieties in the same field for disease resistance is a longstanding agricultural practice, but can have unpredictable results. A study publishing September 12th in the open access journal PLOS Biology by Jean-Benoit Morel at Institut National de Recherche pour l'Agriculture l'Alimentation et l'Environnement, Montpellier, France, and colleagues suggests that plant-to-plant interactions may confer disease immunity in both wheat and rice.
Neighbor-Modulated Susceptibility (NMS) occurs when healthy, same-species ...
Umass Amherst research finds benefits, risks in state-mandated school-based BMI assessments
2023-09-12
A University of Massachusetts Amherst resource economist finds mandated in-school Body Mass Index (BMI) assessments adopted in varying forms by 24 states to combat childhood obesity have the potential to improve the health of some students while introducing body-image issues for others. The research is believed to be the first to assess these policies as a whole, rather than in single states or school districts.
“In states that passed these laws, overweight and obese teens were more likely to correctly describe their bodies as such, compared to states ...
LAST 30 PRESS RELEASES:
Twelve questions to ask your doctor for better brain health in the new year
Microelectronics Science Research Centers to lead charge on next-generation designs and prototypes
Study identifies genetic cause for yellow nail syndrome
New drug to prevent migraine may start working right away
Good news for people with MS: COVID-19 infection not tied to worsening symptoms
Department of Energy announces $179 million for Microelectronics Science Research Centers
Human-related activities continue to threaten global climate and productivity
Public shows greater acceptance of RSV vaccine as vaccine hesitancy appears to have plateaued
Unraveling the power and influence of language
Gene editing tool reduces Alzheimer’s plaque precursor in mice
TNF inhibitors prevent complications in kids with Crohn's disease, recommended as first-line therapies
Twisted Edison: Bright, elliptically polarized incandescent light
Structural cell protein also directly regulates gene transcription
Breaking boundaries: Researchers isolate quantum coherence in classical light systems
Brain map clarifies neuronal connectivity behind motor function
Researchers find compromised indoor air in homes following Marshall Fire
Months after Colorado's Marshall Fire, residents of surviving homes reported health symptoms, poor air quality
Identification of chemical constituents and blood-absorbed components of Shenqi Fuzheng extract based on UPLC-triple-TOF/MS technology
'Glass fences' hinder Japanese female faculty in international research, study finds
Vector winds forecast by numerical weather prediction models still in need of optimization
New research identifies key cellular mechanism driving Alzheimer’s disease
Trends in buprenorphine dispensing among adolescents and young adults in the US
Emergency department physicians vary widely in their likelihood of hospitalizing a patient, even within the same facility
Firearm and motor vehicle pediatric deaths— intersections of age, sex, race, and ethnicity
Association of state cannabis legalization with cannabis use disorder and cannabis poisoning
Gestational hypertension, preeclampsia, and eclampsia and future neurological disorders
Adoption of “hospital-at-home” programs remains concentrated among larger, urban, not-for-profit and academic hospitals
Unlocking the mysteries of the human gut
High-quality nanodiamonds for bioimaging and quantum sensing applications
New clinical practice guideline on the process for diagnosing Alzheimer’s disease or a related form of cognitive impairment or dementia
[Press-News.org] Alzheimer’s: An M.D./Ph.D. graduate student’s request for Yuhua Song as mentor leads to two NIH R01 awards totaling $5 millionThe M.D./Ph.D. student has since moved on to clinical studies, but the research into possible drugs to treat Alzheimer’s disease continues.